Serum Proteomic Profile Based on the TGF-Beta Pathway Stratifies Risk of Hepatocellular Carcinoma

By afschroeder • September 9, 2025

Xiang X, Shetty K, Yu H, Mishra B, Wong LL, Zhou XJ, Satapathy SK, Crawford JM, Latham PS, Han SH, Mathew B, Dagher NN, Lau L, Cacaj F, Vegesna AK, Dasarathy S, He AR, Huang H, Amdur RL, Mishra L. Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma. Liver Int. 2025 Oct;45(10):e70325. doi: 10.1111/liv.70325. PMID: 40919824; PMCID: PMC12416123.

Tags: Cirrhosis, Digestive Diseases, early diagnosis, liver cancer, proteomics, Publications, surveillance

Recurrent Barrett’s esophagus-related neoplasia is uncommon after successful endoscopic eradication therapy over long-term follow-up

Enke T, Pokala SK, Hensen C, Brennan C, Gallegos J, Hochheimer CJ, Muthusamy VR, Thaker AM, Kushnir V, Early D, Rastogi A, Hammad H, Edmundowicz[...]

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across Racial and Ethnic Groups

Patel C, Abboud Y, Karkra R, Qureshi I, Gaglio P, Lingiah V, Al-Khazraji A, Hajifathalian K. Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across[...]